Jul 2 2010
North American Installations of Gamma Knife Grow as Innovations Reinforce Perfexion as a Critical Tool for Treating Brain Metastases
The refinements in Elekta’s Gamma Knife® surgery technology that created the fifth generation Leksell Gamma Knife® Perfexion™ are changing the approach to treating brain metastases and other brain disorders. With Perfexion, clinicians are applying therapy to multiple metastases in a single session, treating more non-malignant targets located in critical areas and planning increasingly tailored plans to meet individual patient needs. The result has been an upsurge in Perfexion sales and upgrades in North America.
Elekta recently announced its fourth quarter orders for Leksell Gamma Knife Perfexion, including Methodist Hospital (San Antonio), Memorial Hermann-Texas Medical Center (Houston), NewYork-Presbyterian Hospital and Swedish Cancer Institute (Seattle).
“Since the introduction of Perfexion, 40 percent of Gamma Knife systems in North America are, or will soon be, Perfexion systems,” says Thomas McKay, Senior Marketing Manager for Elekta Neuroscience <http://www.elekta.com/neuroscience> . “The benchmark upon which all other radiosurgery systems are measured, the capabilities of Perfexion continue to evolve, fusing the skills of the clinician with the science of radiosurgery.”